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Th2 Cytokine Profile in Cutaneous T-Cell 
Lymphoma 
To the Editor: 
We rcad with g rca t in terest the article by Saed cl a/ en titled 
"Mycosis fun goides exhibits a T h1- type cell-m ediatcd cytokinc 
profile w hereas Seza ry syndrome expresses a T h2-type profile" in 
the July 1994 issue of the J o urnal of In vestigative Dermatology [1]. 
Using reverse- transcriptase-polym era se chain reactio n (RT -PCR) 
a mplification, the authors dem onstratcd th e prescncc ofmRNA for 
IL- 2 and interferon-ga mma (IFN-y) but no cvidence ofmRN A for 
inte rl eu kin 4 (IL-4), IL-5 , or IL-10 in the epid ermi s of seven 
pa tients with plaque-type mycosis fungo ides (M F) . T his was in 
contrast to the epidermis (n = 3) and th e blood (n = 7) of SezalY 
syndrome (SS) patients that demonstrated message fo r IL- 4, IL- 5, 
and IL-I O, but no eviden ce of IL-2 or IFN-y. T h e fllldings in the 
MF skin is in keeping with a T h1 cytokin c pattcrn and the findin gs 
in the Sezary syndrome skin and blood are in kecping w ith a T h2 
cy.~okine pattcrn . As the title of the articl e implies, the autho r 's 
in terpretation of th ese findings is that the m align an t T cell s of 
mycosis fungoides elabo rate a diffe rent set of cytokin cs than those 
of Sezary syndrom c. O ur gro up has rcccntly published data on 
sin"lilar studics in cu taneous lcs io ns taken fi'om diffe rent stages of 
c utaneous T -cell lympho m a (CTCL) [2). O ur d ata is in partial 
agreement with Saed eI a/; however, because of d iffe ren ces in o ur 
find ings in normal controls, o ur interpretation and conclu sio n is 
that thc malignant T cells in cutaneous T-cel l lympho m a, both in 
mycosis fun goides and Sezary syndro m e, are of a T h 2 subtypc based 
on the express io n of the T h 2 cytokin es. 
It must b e first pointed out that RT -PC R amplifi cation studi es 
su c h as these provide a window into the miciro-environment of the 
skin but cann ot de terminc th e precise source of a particul ar 
a mplification signal, as do ;11 s;11I hybr idization studics. To draw any 
conclusio ns concerning thee so urce of amplifi cation sign als from 
peR experiments, normal contro ls are critical. W e be li cve subtle 
diiFe renccs in o ur techniques havc led to different resul ts in n o rm al 
skin contro ls that ha vc lcd to differen ccs in interpre tation of o ur 
respective data . 
Unlikc Saed el a/, we found amp li fi cation signals fo r IL-2 and 
IFN-y in 100'% of the 12 normal skin contro ls we ana lyzed. Sacd ('/ 
a/ reports that they h ave detected IFN-y mRN A in four of 11 
norma l skins, bu t no IL-2. We believe that ou r techniquc is more 
sensitive than that of Saed ci a/; th is may be re lated to primer 
sel ection. In addition , we analyzed who le p unch biopsies and did 
not separate epidermi s and dermis by heating . Potentia lly, heating 
of the samp les m ay have affected m ore labile transcrip ts . Beca use 
there are n o endogenous skin cells that have been documented to 
secr ete IL-2 o r IFN- y, including Lange rh ans cell s [3] , w e inter-
preted o ur data to indicate that the so urce o f the IL- 2 and IFN-y 
a lnpLifi cation products were ["om normal lymph ocytes tha t traffi c 
through the skin in an activated state [4] . Furthermore , we 
reason ed that our assay ' s detection thresho ld was sensitive enough 
to consistently detect these cells. 
, If IL- 2 and I FN- y, cytokines that counteract th e expression and 
effects of T h2 cyto kincs, are present in detectabl e quantities in 
normal skin , then they ma y have th e poten tial to do wn regulate 
IL- 4 and IL-5 secretio n fi'om infi ltrating T h 2 cells. Furthermore, 
T hl cytokines in hibit Th2 cytokin e mI~A exprcssion. T h e con-
cept of immunorcg ulatio n of the m align ant cells in early CTCL f,ts 
th e natura l history and indo lent nature of the early stages of the 
d iseasc . Studies have shown IFN-y-secreting cytotoxic T cells to be 
present in the infil tratc of MF lesions [5) and thesc m ay influen cc 
the cytokin e ex press io n of mali gnant CD4 cells. 
It is noteworth y that o ur studies provide clcar cviden cc of T h 2 
cytokincs in cutaneous M F lesio ns, particul arl y tum o r stage di scase 
in w hi ch the disease is aggress ive and poorl y regul ated. In six of six 
bio pies fi 'oll1 cutaneous tumors from M F patients, we d e tected T h 2 
cyto kine mRNA. Moreover, we also de tected T h 2 cytokin e 
ml~A in three of six sa mp les from pati encs with early patch- or 
plaqu c-stage disease. T hus, we in te rprct T hl sign als in early MF 
les ions to be a result o f e ithcr norm al trafficking lymphocytes o r a 
tUlllor-inflltratin g host response w ith a predominan ce of Th1 
cytokin es th at ma y supress cyto kin e gene transcriptio n of M F tumo r 
cclls. 
The m ost coh esive, bio logica lly re levant m odel to explain the 
T h1 findin gs in ea rl y MF is that CTCL is a malignancy of a T h 2 
C D4 T - ce ll that is down regul ated in ea rly d isease b y T hl cells . 
T his wou ld explain wh y R T -PC R demo nstl'a tes a T hl pro fi le in 
earl y skin d isease . T his m o d el excl udes the unp roved speculation 
that a hu man T h1 cell is capable of differentiating into a T h 2 cell as 
suggested by Saed ct a/. W e believe that the findings of th e T h I 
pro fil e in both papers are compatible w ith a T h2 m odel of CTCL 
and that the attem pt to use a di chotomo us paradig m of cyto kin e 
secretion of m ycosis fungo ides an d Sezary syndro llle is misle ading 
and in accura te . /11 s;11I hybridization studies w ill hopcfu ll y reso lve 
this issuc w ith certain ty. 
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We do not believe there is a controversy regarding our published 
conclusion [1] that the m alignant T cell s in cutaneous T-cell 
lymphom a (CTCL) most closely resemble murine T -helper type 2 
cell s. Our overall findings dea lt with' cytokine networks that were 
established in patients w ith d iffe rent clinica l manifestations of 
CTCL. Many diverse cell types contribute to the establishment of 
such networks including endogeno us cell s of the skin as w ell as 
recrui ted benign reactive T cells and malignant T cells. D espite 
widely dive rgent clinical presentations and the confederacy of cell 
types that can produce cytokines, it was clear that reproducible 
patterns of cytokin e networks were present in the epidermal and 
derm al compartments of CTCL patients . In o ur report we pre-
sen ted three possible explanations for the RT-PCR-based results 
in w hich skin biopsies of mycosis fungoides lesions were found to 
contaiy cytokines closely resembling the murine T -helper type 1 
re)ponse, whereas Sezary syndrome samples had cytokin es closely 
resembling the murine T helper type 2 response. Our first and 
favored conclusion of these results, as mentioned above [1], was: 
"The first of these is that aLI mali gnant T ce LI s in CTCL arc ofTh2 
type . .. " We believe th at this sentence , conveys the same message 
as the letter of Lessin el a/. Indeed , we had previously o bserved in 
1989 the inabili ty of circulating Sezary cells to produce IFN-')I [2], 
which supports o ur contention that the malignant tumor cell s 
belong in the category of the T -helper type 2 cells. M ore recentl y, 
usin g immunostaining we locali zed an important Th-2 type cyto-
kine, IL-10, to the malignant T cells ill 1I i1)D and to a Sezary cell lin e 
ill lI il l'o [3 ,4]. 
We believe that the cytokine prod uction p rofile of an individual 
T cell could be influenced by loca lmicroen vironmental factors. W e 
have demonstrated that local facto rs such as the nature of the 
antigen-presenting ce ll (APC) ca n signifi can tly determine whether 
a T-cell-prolife rative response is accompanied by a T h-1 type 
versus T h-2 type cytokine production profi le [5]. Using resting 
peripheral blood-derived T cell s and an identica l antigenic stimulus 
(bacterial-derived superantigen-relevant to CTCL r6]) , a T h-2 type 
cytokin e profi le results if keratinocytes were used as the " n on-
professional" type of APC, whereas a Th-l type cytokine response 
was produced using dermal dendritic ce ll s as the " professional" 
type of APC (7]. Because the T h-2 response could be con verted to 
a T h-1 type response by adding IL-12, we explored the poss ibl e 
in volve ment o flL-1 2 in CTCL. In a study that is currently subitted 
for publication, we h ave observed that treatment regimens used for 
CTCL such as photopheresis and psoralen plus ultrav io let A grea tly 
increased rL-12 levels, w hi ch cou ld retard the pro li feration of the 
malignan t T h-2 type ce ll s. Another in triguing observation re levant 
to the characte rization of the malignant T cells in CTCL [8] had 
been the recognition tha t these cells co-express CD28 and the 
co- stimulatory m o lecule B7-1 (CD80). Such dual expression could 
facilitate autostimulation between malignan t T cell s and lead to 
their proliferation becoming independent of the necessity fo r 
interaction with APCs to prov ide co- stimulation. At least on e 
report has demonstrated when T cells inte ract with APCs in a 
CD28:B7-dependent fashion that a T h- 1 type response ensued , 
whereas, if this pathway is blocked, a T h-2 type response occurs 
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[9] . T hus, it is possible that by acquIrIng co-express ion of both 
ligand and receptor (CD28 and B7-1) the malignant T - cell clone 
could perpetuate itselfin an APC-independent fashion and produ ce 
predo min antl y T h-2 type cytokines . A recent abstract [10] demon-
strates that cu ltu red Sezary cells utilize C D 28 mediated co-stimu-
lation fo r the if pro liferation, although no ill I) ill"o cytokine produc-
tion profi les were indica ted . 
M an y new and exciting revelation s regarding the immunology 
and pathophysio logy of CTCL are em erging. Microenviro l1m ental 
factors may be important in CTCL, and th e Th-2 type nature of 
malign ant T - cell clones m ay well represen t the coll ective influence 
of neighbbOl;ng professional and non-professional APCs (keratino-
cytes and dendritic cells), via the ir expressio n of re levant co-
stimulato ry signal s (mediated via CD28) and production of cyto-
kines (IL-10 and IL-12) . Such new insights may lead to a better 
understanding of the factors that are important in the em ergence of 
such m aLign ant T ce lJ clones ;11 1) ; 110 and to better success in 
propagating these T h-2 type cells ill IJilro . 
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Mutations in the Laniinin 5 LAMB3 Gene in 
Generalized Atrophic Benign Epidermolysis Bullosa 
To the Edito r: 
I h ave read with interest the paper of M cG ra th ci tI/ [1] in the Apri l 
1995 issue and con gratul ate the authors, especially Drs. C hristiano 
and Uitto , for successfull y identifyin g th e mu tations in domain VI 
of the lam in in 5 {33 chain sho rt arm as underlying m o lecular defects 
in their fa mil y with th e no n-lethal mitis type of junctional ED. 
N evertheless, I would like to comment on the authors' citation 
m ode stating that this type of junctional ED had been described fo r 
the fIrst time by Hintner and Wolff in 1982 [2] . T his is not correct. 
In f.1 ct, the first case of this beni gn, non-lethal junctional ED type in 
the world li terature had been reported by Hashimoto ci tI/ in 1976 
[3], delineating this form as a distinct variant of ED and describing 
